3Navarro JF,Mora C.Role of inflammation in diabetic complications[J].Nephrol Dial Transplant,2005,20(12):2601-2604.
4Willerson JT,Ridker PM.Inflammation as a cardiovascular risk factor[J].Circulation,2004,109(21):II2-II10.
5Dalla M,Mussap M,Gallina P,et al.Acute-phase markers of inflammation and glomerular structure in patients with type 2 diabetes[J].J Am Soc Nephrol,2005,16(1):S78-S82.
6Zinman B,Hanley AJ,Harris SB,et al.Circulating tumor necrosis factor-alpha concentrations in a native Canadian population with high rates of type 2diabetes mellitus[J].Clin Endocrinol Metab,1999,84(1):272-278.
7Festa A,Agostino R,Howard G.Inflammation and microalbuminuria in nondiabetic and type 2 diabetic subjects:The Insulin Resistance Atherosclerosis Study[J].Kidney Int,2000,58(4):1703-1710.
8Navarro JF,Mora C,Maca M.Inflammatory parameters are independently associated with urinary albumin in type 2 diabetes mellitus[J].Am J Kidney Dis,2003,42(1):53-61.
9Chen MP,Chung FM,Chang DM,et al.Elevated plasma level of visfatin/pre-B colony-enhancing factor in patients with type 2 diabetes mellitus[J].J Clin Endocrinol Metab,2006,91(1):295-299.
10Dogru T,Sonmez A,Tasci I,et al.Plasma visfatin levels in patients with newly diagnosed and untreated type 2 diabeted mellitus and impaired glucose tolerance[J].Diabetes Res Clin Pract,2007,76(1):24-29.
